HLB Life Science Co., Ltd. (KOSDAQ: 067630)
South Korea
· Delayed Price · Currency is KRW 9,360.00
-990.00 (-9.57%)
Oct 11, 2024, 9:00 AM KST
HLB Life Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 92,870 | 97,990 | 99,591 | 53,494 | 91,797 | 112,435 | Upgrade
|
| Other Revenue | -0 | - | 0 | 0 | -0 | 1,584 | Upgrade
|
| Revenue | 92,870 | 97,990 | 99,591 | 53,494 | 91,797 | 114,019 | Upgrade
|
| Revenue Growth (YoY) | -22.84% | -1.61% | 86.17% | -41.73% | -19.49% | 11.26% | Upgrade
|
| Cost of Revenue | 95,815 | 98,915 | 102,813 | 59,155 | 89,630 | 106,647 | Upgrade
|
| Gross Profit | -2,945 | -925.04 | -3,222 | -5,661 | 2,167 | 7,371 | Upgrade
|
| Selling, General & Admin | 15,701 | 15,226 | 10,839 | 8,247 | 7,959 | 9,191 | Upgrade
|
| Research & Development | 5,732 | 5,454 | 4,349 | 3,846 | 1,431 | 1,429 | Upgrade
|
| Other Operating Expenses | 308.64 | 279 | 192.67 | 113.46 | 211.74 | 157.62 | Upgrade
|
| Operating Expenses | 24,984 | 24,568 | 16,728 | 12,668 | 10,184 | 12,748 | Upgrade
|
| Operating Income | -27,930 | -25,493 | -19,950 | -18,329 | -8,018 | -5,377 | Upgrade
|
| Interest Expense | -22,307 | -21,650 | -9,870 | -1,256 | -2,109 | -7,633 | Upgrade
|
| Interest & Investment Income | 1,428 | 1,288 | 1,203 | 512.76 | 1,715 | 3,541 | Upgrade
|
| Earnings From Equity Investments | -2,429 | -2,537 | 2,602 | - | - | 802.86 | Upgrade
|
| Currency Exchange Gain (Loss) | 19.37 | -93.22 | 33.77 | -4.05 | 111.25 | -44.86 | Upgrade
|
| Other Non Operating Income (Expenses) | 3,733 | 608.32 | -2,664 | -60.63 | 1,548 | -4,817 | Upgrade
|
| EBT Excluding Unusual Items | -47,484 | -47,877 | -28,646 | -19,137 | -6,752 | -13,528 | Upgrade
|
| Gain (Loss) on Sale of Investments | 80,170 | 81,197 | -20,548 | -21,296 | -27,533 | 40,131 | Upgrade
|
| Gain (Loss) on Sale of Assets | -304.96 | -304.96 | 3,157 | 594.55 | 313.04 | -37.9 | Upgrade
|
| Asset Writedown | -37,553 | -37,553 | -14,802 | -13,786 | -22,519 | -27,014 | Upgrade
|
| Other Unusual Items | -1,966 | -1,966 | - | - | - | -6,113 | Upgrade
|
| Pretax Income | -7,138 | -6,503 | -60,839 | -53,624 | -56,490 | -6,561 | Upgrade
|
| Income Tax Expense | 1,981 | -590.06 | -6,479 | -4,333 | -654.25 | 1,002 | Upgrade
|
| Earnings From Continuing Operations | -9,119 | -5,913 | -54,360 | -49,292 | -55,836 | -7,563 | Upgrade
|
| Net Income to Company | -9,119 | -5,913 | -54,360 | -49,292 | -55,836 | -7,563 | Upgrade
|
| Minority Interest in Earnings | -85.34 | -70.35 | 82.24 | 139.89 | 38.95 | -41.61 | Upgrade
|
| Net Income | -9,205 | -5,983 | -54,277 | -49,152 | -55,797 | -7,605 | Upgrade
|
| Net Income to Common | -9,205 | -5,983 | -54,277 | -49,152 | -55,797 | -7,605 | Upgrade
|
| Shares Outstanding (Basic) | 106 | 102 | 101 | 99 | 99 | 93 | Upgrade
|
| Shares Outstanding (Diluted) | 106 | 102 | 101 | 99 | 99 | 93 | Upgrade
|
| Shares Change (YoY) | 0.69% | 0.80% | 1.64% | 0.34% | 6.39% | 54.49% | Upgrade
|
| EPS (Basic) | -87.19 | -58.79 | -537.56 | -494.76 | -563.59 | -81.72 | Upgrade
|
| EPS (Diluted) | -87.19 | -58.79 | -537.56 | -494.76 | -563.85 | -81.77 | Upgrade
|
| Free Cash Flow | -55,582 | -30,634 | -40,420 | -16,505 | -6,400 | -21,465 | Upgrade
|
| Free Cash Flow Per Share | -526.53 | -300.99 | -400.32 | -166.14 | -64.64 | -230.65 | Upgrade
|
| Gross Margin | -3.17% | -0.94% | -3.23% | -10.58% | 2.36% | 6.47% | Upgrade
|
| Operating Margin | -30.07% | -26.02% | -20.03% | -34.26% | -8.73% | -4.72% | Upgrade
|
| Profit Margin | -9.91% | -6.11% | -54.50% | -91.88% | -60.78% | -6.67% | Upgrade
|
| Free Cash Flow Margin | -59.85% | -31.26% | -40.59% | -30.85% | -6.97% | -18.83% | Upgrade
|
| EBITDA | -21,168 | -17,797 | -14,727 | -15,845 | -5,763 | -3,475 | Upgrade
|
| EBITDA Margin | -22.79% | -18.16% | -14.79% | -29.62% | -6.28% | -3.05% | Upgrade
|
| D&A For EBITDA | 6,762 | 7,696 | 5,223 | 2,484 | 2,255 | 1,902 | Upgrade
|
| EBIT | -27,930 | -25,493 | -19,950 | -18,329 | -8,018 | -5,377 | Upgrade
|
| EBIT Margin | -30.07% | -26.02% | -20.03% | -34.26% | -8.73% | -4.72% | Upgrade
|
| Advertising Expenses | - | 157.86 | 69.13 | 34.92 | 41.38 | 143.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.